Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Mar 24, 2023

SELL
$0.59 - $0.9 $295 - $450
-500 Closed
0 $0
Q2 2019

Mar 24, 2023

BUY
$0.79 - $1.11 $395 - $555
500 New
500 $428,000
Q1 2019

Mar 24, 2023

BUY
$0.6 - $1.41 $300 - $705
500 New
500 $545,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.